iSpecimen Announces Closing of Over-Allotment Option in Connection with its Initial Public Offering By isp_developer | August 9, 2021 Read More
iSpecimen® expands offerings to support regenerative medicine, adding cryopreserved stem and immune cells to existing biospecimens available through iSpecimen Marketplace™ By isp_developer | February 3, 2021 Read More
Pathology Lab and Health Information Exchange Partner with iSpecimen® to Bring COVID-19 Specimens to Researchers By isp_developer | December 17, 2020 Read More
Tracy Wilson Curley joins iSpecimen® as Chief Financial Officer By isp_developer | September 30, 2020 Read More
iSpecimen® and myOnsite HealthCare deploy mobile phlebotomy to help advance research during the coronavirus pandemic By isp_developer | May 20, 2020 Read More
iSpecimen® to supply CDC with blood samples to help advance understanding of COVID-19 immunity By isp_developer | May 12, 2020 Read More
iSpecimen® marshalling novel coronavirus specimens to front lines of research By isp_developer | April 16, 2020 Read More
